Palliative Therapies for Congenital Heart Disease with Ductus Dependent Pulmonary Circulation

Abstract

In neonates, the management of ductus dependent pulmonary circulation is challenging. There have been three palliative therapies for this lesion: the modified Blalock-Taussig shunt, ductal stenting and prostaglandin E infusions, for maintaining the ductal patency before definite operations. Debates remain with regard to the indications and disadvantages of three palliative therapies. The aim of this article is to give a brief review of these three palliative therapies.

Key words

congenital heart defects - ductus arteriosus - pulmonary circulation.

• References

• 1 Gournay V. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies. Arch Cardiovasc Dis 2011; 104: 578-585
• 2 Habshan FA. Ductal-dependent forms of congenital heart disease: clinical significance of prenatal diagnosis. http://www.sha-conferences.com/files/presentation2011/005004.pdf, Accessed on March 25, 2017
• 3 Viñals F, Tapia J, Giuliano A. Prenatal detection of ductal-dependent congenital heart disease: how can things be made easier?. Ultrasound Obstet Gynecol 2002; 19: 246-249
• 4 Kouatli A. Ductus arteriosus dependent congenital heart disease. www.sha-education.com/sites/all/sha23_presentations/27-1-2012/007002.pdf Accessed on March 25, 2017
• 5 Hussain A, Al-Zharani S, Muhammed AA. et al. Midterm outcome of stent dilatation of patent ductus arteriosus in ductal-dependent pulmonary circulation. Congenit Heart Dis 2008; 3: 241-249
• 6 Yuan SM, Shinfeld A, Raanani E. The Blalock-Taussig shunt. J Card Surg 2009; 24: 101-108
• 7 Metras D, Kreitmann B, Riberi A. et al. A simple approach to takedown of a modified Blalock shunt. Ann Thorac Surg 1992; 53: 912-913
• 8 Küçük M, Özdemir R, Karaçelik M. et al. Risk factors for thrombosis, overshunting and death in infants after modified Blalock-Taussig shunt. Acta Cardiol Sin 2016; 32: 337-342
• 9 McMullan DM, Permut LC, Jones TK. et al. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow. J Thorac Cardiovasc Surg 2014; 147: 397-401
• 10 Yun SW. Congenital heart disease in the newborn requiring early intervention. Korean J Pediatr 2011; 54: 183-191
• 11 Akaike T, Minamisawa S. Prostaglandin E-mediated vascular remodeling of the ductus arteriosus and ductus-dependent congenital heart diseases. J Mol Genet Med 2016; 10: e109 10.4172/1747-0862.1000e109
• 12 Gruzdev A, Nguyen M, Kovarova M. et al. PGE₂ through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth. Prostaglandins Other Lipid Mediat 2012; 97: 109-119
• 13 Aydın B, Dilli D, Zenciroğlu A. et al. Intussusception in a term newborn with duct-dependent congenital heart disease. Dicle Tıp Dergisi 2013; 40: 105-108
• 14 Huang FK, Lin CC, Huang TC. et al. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Pediatr Neonatol 2013; 54: 102-106
• 15 Ustün N, Dilli D, Zenciroğlu A. et al. Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey. Anadolu Kardiyol Derg 2013; 13: 732-734
• 16 Silove ED, Roberts DG, de Giovanni JV. Evaluation of oral and low dose intravenous prostaglandin E₂ in management of ductus dependent congenital heart disease. Arch Dis Child 1985; 60: 1025-1030
• 17 Kobayashi N, Aida N, Nishimura G. et al. Acute gastric outlet obstruction following the administration of prostaglandin: an additional case. Pediatr Radiol 1997; 27: 57-59
• 18 Sivakumar K, Bhagyavathy A, Coelho R. et al. Longevity of neonatal ductal stenting for congenital heart diseases with duct-dependent pulmonary circulation. Congenit Heart Dis 2012; 7: 526-533
• 19 Santoro G, Gaio G, Capozzi G. et al. Fate of hypoplastic pulmonary arteries after arterial duct stenting in congenital heart disease with duct-dependent pulmonary circulation. JACC Cardiovasc Interv 2015; 8: 1626-1632
• 20 Buys DG, Brown SC, Greig C. Stenting the arterial duct: practical aspects and review of outcomes. SAHeart 2013; 10: 514-519
• 21 Alwi M, Choo KK, Latiff HA. et al. Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol 2004; 44: 438-445